1 / 13

Leading the Way in Cardiovascular Regenerative Medicine

CV disease: US prevalence. American Heart Association. Heart Disease and Stroke Statistics2007 Update.. Myocardial ischemia 37 million*. Acute MI 865,000/year. Heart failure 5 million. Peripheral vascular disease 8 million . Stroke 5.7 million. Chest Pain4.2 million emergency visits/year 6.4

brenna
Télécharger la présentation

Leading the Way in Cardiovascular Regenerative Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Leading the Way in Cardiovascular Regenerative Medicine This slide set presents the current work in cell therapy in treating cardiovascular (CV) disease. Types of cells used, how therapy is delivered, results of recent studies in regenerative medicine, and what the future holds for cell therapy research are included.This slide set presents the current work in cell therapy in treating cardiovascular (CV) disease. Types of cells used, how therapy is delivered, results of recent studies in regenerative medicine, and what the future holds for cell therapy research are included.

    2. CV disease: US prevalence

More Related